Ten kHz spinal cord stimulation for the treatment of chronic peripheral polyneuropathy: 12‐Month results from prospective open‐label pilot study. Issue 8 (25th August 2021)

• Record Type: Journal Article
• Authors: Galan, Vincent; Scowcroft, James; Chang, Paul; Li, Sean; Staats, Peter; Subbaroyan, Jeyakumar; Caraway, David
• Is Part Of: Pain practice. Volume 21:Issue 8(2021)
• Page Start: 898
• Page End: 906
• Publication Date: 2021-08-25
• Subjects: 10 kHz SCS -- chronic peripheral polyneuropathy -- visual analog scale; Pain -- Treatment -- Periodicals; 616.0472
• DOI: 10.1111/papr.13059
• Languages: English
• ISSNs: 1530-7085

Abstract

Abstract: Background: The goal of this study was to demonstrate that the paresthesia‐independent 10 kHz spinal cord stimulation (SCS) can provide long‐term pain relief in patients with peripheral polyneuropathy (PPN). Clinically diagnosed subjects with PPN refractory to conventional medical management were enrolled in this prospective, multicenter study between November 2015 and August 2016, after institutional review board approval and patient informed consent were obtained. Methods: Subjects underwent trial stimulation utilizing 2 epidural leads, and if successful, were implanted with a permanent 10 kHz SCS system and followed up for 12 months post‐implant. Outcome measures included adverse events, pain, neurological assessments, disability, function, quality of life, pain interference, sleep, satisfaction, and global impression of change. Data are presented as descriptive statistics. Permanent implant population results are reported as mean ± standard error. Results: Twenty‐one of the 26 trialed subjects had a successful trial and 18 received a permanent implant. All subjects had the leads placed anatomically without the need for paresthesia. Subjects experienced significant and sustained pain relief (at least 65% at all timepoints) whereas physicians noted improvements in neurological function. Significant improvements in disability, function, sleep, sensory, and affective dimensions of pain were reported at all timepoints. All adverse events were resolved without sequelae. Conclusion: Findings from this study suggest that 10 kHz SCS may provide sustained pain relief and disability improvements in patients suffering from PPN.